These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29195086)

  • 1. Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease.
    Bulk M; Abdelmoula WM; Nabuurs RJA; van der Graaf LM; Mulders CWH; Mulder AA; Jost CR; Koster AJ; van Buchem MA; Natté R; Dijkstra J; van der Weerd L
    Neurobiol Aging; 2018 Feb; 62():231-242. PubMed ID: 29195086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.
    Bulk M; Kenkhuis B; van der Graaf LM; Goeman JJ; Natté R; van der Weerd L
    J Alzheimers Dis; 2018; 65(4):1125-1137. PubMed ID: 30103327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease.
    van Rooden S; Doan NT; Versluis MJ; Goos JD; Webb AG; Oleksik AM; van der Flier WM; Scheltens P; Barkhof F; Weverling-Rynsburger AW; Blauw GJ; Reiber JH; van Buchem MA; Milles J; van der Grond J
    Neurobiol Aging; 2015 Jan; 36(1):20-6. PubMed ID: 25113794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Iron Reflects Severity of Alzheimer's Disease.
    van Duijn S; Bulk M; van Duinen SG; Nabuurs RJA; van Buchem MA; van der Weerd L; Natté R
    J Alzheimers Dis; 2017; 60(4):1533-1545. PubMed ID: 29081415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7T MRI allows detection of disturbed cortical lamination of the medial temporal lobe in patients with Alzheimer's disease.
    Kenkhuis B; Jonkman LE; Bulk M; Buijs M; Boon BDC; Bouwman FH; Geurts JJG; van de Berg WDJ; van der Weerd L
    Neuroimage Clin; 2019; 21():101665. PubMed ID: 30642758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease.
    Zeineh MM; Chen Y; Kitzler HH; Hammond R; Vogel H; Rutt BK
    Neurobiol Aging; 2015 Sep; 36(9):2483-500. PubMed ID: 26190634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
    Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
    J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter microstructural damage in Alzheimer's disease at different ages of onset.
    Canu E; Agosta F; Spinelli EG; Magnani G; Marcone A; Scola E; Falautano M; Comi G; Falini A; Filippi M
    Neurobiol Aging; 2013 Oct; 34(10):2331-40. PubMed ID: 23623599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cortical iron and tau aggregation in Alzheimer's disease.
    Spotorno N; Acosta-Cabronero J; Stomrud E; Lampinen B; Strandberg OT; van Westen D; Hansson O
    Brain; 2020 May; 143(5):1341-1349. PubMed ID: 32330946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
    Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The topography of grey matter involvement in early and late onset Alzheimer's disease.
    Frisoni GB; Pievani M; Testa C; Sabattoli F; Bresciani L; Bonetti M; Beltramello A; Hayashi KM; Toga AW; Thompson PM
    Brain; 2007 Mar; 130(Pt 3):720-30. PubMed ID: 17293358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
    J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease.
    Cho H; Jeon S; Kang SJ; Lee JM; Lee JH; Kim GH; Shin JS; Kim CH; Noh Y; Im K; Kim ST; Chin J; Seo SW; Na DL
    Neurobiol Aging; 2013 Jul; 34(7):1921.e9-1921.e15. PubMed ID: 23391426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker.
    van Rooden S; Versluis MJ; Liem MK; Milles J; Maier AB; Oleksik AM; Webb AG; van Buchem MA; van der Grond J
    Alzheimers Dement; 2014 Jan; 10(1):e19-26. PubMed ID: 23712002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
    Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer's disease.
    Kuchcinski G; Patin L; Lopes R; Leroy M; Delbeuck X; Rollin-Sillaire A; Lebouvier T; Wang Y; Spincemaille P; Tourdias T; Hacein-Bey L; Devos D; Pasquier F; Leclerc X; Pruvo JP; Verclytte S
    Eur Radiol; 2023 Jan; 33(1):184-195. PubMed ID: 35881183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative MRI and laser ablation-inductively coupled plasma-mass spectrometry imaging of iron in the frontal cortex of healthy controls and Alzheimer's disease patients.
    Bulk M; Abdelmoula WM; Geut H; Wiarda W; Ronen I; Dijkstra J; van der Weerd L
    Neuroimage; 2020 Jul; 215():116808. PubMed ID: 32289451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulcal morphology as a new imaging marker for the diagnosis of early onset Alzheimer's disease.
    Hamelin L; Bertoux M; Bottlaender M; Corne H; Lagarde J; Hahn V; Mangin JF; Dubois B; Chupin M; de Souza LC; Colliot O; Sarazin M
    Neurobiol Aging; 2015 Nov; 36(11):2932-2939. PubMed ID: 26256787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.